Literature DB >> 7127838

Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum.

O Niemelä, L Risteli, E A Sotaniemi, J Risteli.   

Abstract

Inhibition curves that are considerably less steep than the reference peptide curve are a constant finding when human serum samples are studied with the radioimmunoassay for the aminoterminal propeptide Col 1-3 of type III procollagen. This is due to the presence in the serum of three main peptide forms which differ in their antigenic properties and can be separated by gel filtration. Their molecular sizes are, respectively, larger than, equal to and smaller than the peptide Col 1-3. The proportions of these forms were different in a number of serum samples tested. An elevated value in the Col 1-3 radioimmunoassay need not reflect increased deposition of type III collagen in the liver, but could also be due to increased degradation of a newly-synthesized type III procollagen or degradation of a tissue form still containing the aminoterminal propeptide. This should be considered when interpreting elevated serum values.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7127838     DOI: 10.1016/0009-8981(82)90317-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Purification of human procollagen type III N-proteinase from placenta and preparation of antiserum.

Authors:  R Halila; L Peltonen
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

2.  An immunohistochemical and serum ELISA study of type I and III procollagen aminopropeptides in primary biliary cirrhosis.

Authors:  B H Davis; J A Madri
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

3.  Transpulmonary gradient of type III procollagen peptides: acute effects of cardio-pulmonary bypass.

Authors:  N K Harrison; G J Laurent; T W Evans
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

4.  Aminoterminal propeptide of type III procollagen in healing wound in humans.

Authors:  K Haukipuro; L Risteli; M I Kairaluoma; J Risteli
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

5.  Purification and characterization of the N-terminal propeptide of human type III procollagen.

Authors:  O Niemelä; L Risteli; J Parkkinen; J Risteli
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

6.  Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis.

Authors:  H Nakano; H Nakabayashi; Y Okamoto; T Kawasaki; S Seko; Y Fukuda
Journal:  Gastroenterol Jpn       Date:  1985-12

7.  Serum laminin--its concentration increases with portal hypertension in cirrhotic liver disease.

Authors:  A M Gressner; W Tittor
Journal:  Klin Wochenschr       Date:  1986-12-01

8.  The significance of the aminoterminal propeptide of type III procollagen in paroxysmal nocturnal haemoglobinuria and myelofibrosis.

Authors:  E Vellenga; N H Mulder; A K van Zanten; H O Nieweg; M G Woldring
Journal:  Eur J Nucl Med       Date:  1983

9.  Type III collagen metabolism in soft tissue sarcomas.

Authors:  T A Wiklund; I Elomaa; C P Blomqvist; L Risteli; J Risteli
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.